Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Medtronic
MDT
|
$464M |
| 2 |
Exxon Mobil
XOM
|
$299M |
| 3 |
FedEx
FDX
|
$289M |
| 4 |
Netflix
NFLX
|
$273M |
| 5 |
Micron Technology
MU
|
$265M |
Top Sells
| 1 |
Amazon
AMZN
|
$290M |
| 2 |
Electronic Arts
EA
|
$285M |
| 3 |
Mastercard
MA
|
$269M |
| 4 |
RAI
Reynolds American Inc
RAI
|
$245M |
| 5 |
Johnson & Johnson
JNJ
|
$237M |
Sector Composition
| 1 | Healthcare | 15.71% |
| 2 | Technology | 15.39% |
| 3 | Financials | 11.4% |
| 4 | Industrials | 9.47% |
| 5 | Consumer Staples | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Ambev
ABEV
$34.1B
| – | – |
-5,532,700
| Closed | -$30.4M |
|
3552
Abbott
ABT
$231B
| – | – |
-1,065,566
| Closed | -$51.8M |
|
3553
AC Immune
ACIU
$216M
| – | – |
-20,100
| Closed | -$177K |
|
3554
Axcelis
ACLS
$2.48B
| – | – |
-63,099
| Closed | -$1.32M |
|
3555
Aclaris Therapeutics
ACRS
$224M
| – | – |
-28,900
| Closed | -$784K |
|
3556
First Majestic Silver
AG
$4.43B
| – | – |
-66,400
| Closed | -$551K |
|
|
AGEN
3557
Agenus
AGEN
$137M
| – | – |
-24,447
| Closed | -$1.88M |
|
3558
Albemarle
ALB
$9.33B
| – | – |
-32,008
| Closed | -$3.38M |
|
|
ALEX
3559
Alexander & Baldwin
ALEX
$1.39B
| – | – |
-58,013
| Closed | -$2.4M |
|
3560
Ambarella
AMBA
$3.44B
| – | – |
-23,200
| Closed | -$1.13M |
|
3561
AMC Entertainment Holdings
AMC
$1.4B
| – | – |
-7,370
| Closed | -$1.68M |
|
|
AMED
3562
DELISTED
Amedisys
AMED
| – | – |
-28,618
| Closed | -$1.8M |
|
3563
Affiliated Managers Group
AMG
$6.62B
| – | – |
-76,969
| Closed | -$12.8M |
|
3564
AMN Healthcare
AMN
$775M
| – | – |
-86,200
| Closed | -$3.37M |
|
3565
Ameriprise Financial
AMP
$48.3B
| – | – |
-42,000
| Closed | -$5.35M |
|
|
3566
Amazon
AMZN
$2.51T
| – | – |
-5,991,100
| Closed | -$290M |
|
3567
Angi Inc
ANGI
$794M
| – | – |
-15,030
| Closed | -$1.92M |
|
|
ANSS
3568
DELISTED
Ansys
ANSS
| – | – |
-138,729
| Closed | -$16.9M |
|
3569
Aptiv
APTV
$17.5B
| – | – |
-308,500
| Closed | -$27M |
|
3570
Arrowhead Research
ARWR
$3.87B
| – | – |
-374,164
| Closed | -$606K |
|
3571
AdvanSix
ASIX
$565M
| – | – |
-30,000
| Closed | -$937K |
|
3572
ASML
ASML
$296B
| – | – |
-531,050
| Closed | -$69.2M |
|
3573
Astec Industries
ASTE
$1.07B
| – | – |
-61,645
| Closed | -$3.42M |
|
3574
Atkore
ATKR
$1.96B
| – | – |
-9,300
| Closed | -$210K |
|
3575
Actinium Pharmaceuticals
ATNM
$52.7M
| – | – |
-382
| Closed | -$14K |
|